Stock Research for BNDX


Featured Broker: Ally Invest

Get the due diligence for another stock.


BNDX Stock Chart & Research Data

The BNDX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BNDX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


BNDX Due diligence Resources & Stock Charts

The BNDX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BNDX Detailed Price Forecast - CNN Money CNN View BNDX Detailed Summary - Google Finance
Yahoo View BNDX Detailed Summary - Yahoo! Finance Zacks View BNDX Stock Research & Analysis -

Stock Analysis

TradeIdeas View BNDX Trends & Analysis - Trade-Ideas Barrons View BNDX Major Holders - Barrons
NASDAQ View BNDX Call Transcripts - NASDAQ Seeking View BNDX Breaking News & Analysis - Seeking Alpha
Spotlight View BNDX Annual Report - OTC Report View BNDX OTC Short Report -
TradeKing View BNDX Fundamentals - TradeKing Charts View BNDX SEC Filings - Bar Chart
WSJ View Historical Prices for BNDX - The WSJ Morningstar View Performance/Total Return for BNDX - Morningstar
MarketWatch View the Analyst Estimates for BNDX - MarketWatch CNBC View the Earnings History for BNDX - CNBC
StockMarketWatch View the BNDX Earnings - StockMarketWatch MacroAxis View BNDX Buy or Sell Recommendations - MacroAxis
Bullish View the BNDX Bullish Patterns - American Bulls Short Pains View BNDX Short Pain Metrics -

Social Media Mentions

StockTwits View BNDX Stock Mentions - StockTwits PennyStocks View BNDX Stock Mentions - PennyStockTweets
Twitter View BNDX Stock Mentions - Twitter Invest Hub View BNDX Investment Forum News - Investor Hub
Yahoo View BNDX Stock Mentions - Yahoo! Message Board Seeking Alpha View BNDX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for BNDX - Insider Cow View Insider Transactions for BNDX - Insider Cow
CNBC View BNDX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BNDX - OTC Markets
Yahoo View Insider Transactions for BNDX - Yahoo! Finance NASDAQ View Institutional Holdings for BNDX - NASDAQ

Stock Charts

FinViz View BNDX Stock Insight & Charts - StockCharts View BNDX Investment Charts -
BarChart View BNDX Stock Overview & Charts - BarChart Trading View View BNDX User Generated Charts - Trading View

Latest Financial News for BNDX

Vanguard Announces Plans To Launch Total World Bond ETF
Posted on Monday May 21, 2018

VALLEY FORGE, Pa., May 21, 2018 /PRNewswire/ -- Vanguard today filed a preliminary registration statement with the Securities and Exchange Commission for Vanguard Total World Bond ETF. The fund will be structured as an ETF of ETFs, investing directly in two existing low-cost ETFs: Vanguard Total Bond Market ETF (BND) and Vanguard Total International Bond ETF (BNDX). This structure enables the Vanguard Total World Bond ETF to achieve immediate scale by using existing exposure from the underlying ETFs and is expected to result in tighter bid/ask spreads and lower operating expenses than investing directly in the benchmark's constituents.

One Of This Top Asset-Gathering Bond ETFs Has Little US Debt
Posted on Thursday April 26, 2018

Year-to-date, three fixed income exchange-traded funds are among the top 10 ETFs in terms of new assets added. The iShares Short Treasury Bond ETF (NYSE: SHV ) and the iShares Core Aggregate Bond ETF (NYSE: ...

Global Bond ETF Investors Eye China Exposure
Posted on Friday March 23, 2018

Global bond ETF investors that track the benchmark Bloomberg Barclays Global Aggregate Index may soon have exposure to Chinese renminbi-denominated government and policy bank securities. Bloomberg announced ...

BiondVax and NIH Sign Clinical Trial Agreement for a Phase 2 Trial in the U.S. with BiondVax's Universal Flu Vaccine
Posted on Monday November 20, 2017

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) today announced the signing of the clinical trial agreement (CTA) for a Phase 2 clinical trial with the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The study is titled "A Phase II, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial to Assess the Safety, Reactogenicity, and Immunogenicity of Two Doses of Multimeric-001 (M-001) Followed by Seasonal Trivalent Influenza Vaccine." It is designed to evaluate the cell mediated immunity directly induced by BiondVax's universal flu vaccine candidate M-001, as well as M-001's priming effect to enhance the immunogenicity of current seasonal influenza vaccines.

Enter a stock symbol to view the stock details.